Literature DB >> 18475787

Antiviral metal complexes.

E De Clercq1.   

Abstract

The initial events (virus adsorption and fusion with the cells) in the replicative cycle of human immunodeficiency virus (HIV) can serve as targets for the antiviral action of metal-binding compounds such as polyanionic compounds (polysulfates, polysulfonates, polycarboxylates, polyoxometalates, and sulfonated or carboxylated metalloporphyrins), bicyclams and G-octet-forming oligonucleotides. The adsorption and fusion of HIV with its target cells depends on the interaction of the viral envelope glycoproteins (gp 120) with the receptors (CD4, CXCR4) at the outer cell membrane. We are currently investigating how the aforementioned compounds interfere with these viral glycoproteins and/or cell receptor.

Entities:  

Year:  1997        PMID: 18475787      PMCID: PMC2365060          DOI: 10.1155/MBD.1997.173

Source DB:  PubMed          Journal:  Met Based Drugs        ISSN: 0793-0291


  4 in total

Review 1.  Some nontoxic metal-based drugs for selected prevalent tropical pathogenic diseases.

Authors:  Saliu A Amolegbe; Caroline A Akinremi; Sheriff Adewuyi; Amudat Lawal; Mercy O Bamigboye; Joshua A Obaleye
Journal:  J Biol Inorg Chem       Date:  2016-11-30       Impact factor: 3.358

2.  Screening possible drug molecules for Covid-19. The example of vanadium (III/IV/V) complex molecules with computational chemistry and molecular docking.

Authors:  Manos C Vlasiou; Kyriaki S Pafti
Journal:  Comput Toxicol       Date:  2021-01-30

3.  Inhibition of dengue virus serotype 2 in Vero cells with [Cu(2,4,5-triphenyl-1H-imidazole) 2(H2O)2].Cl2.

Authors:  Teguh H Sucipto; Fahimah Martak
Journal:  Infect Dis Rep       Date:  2020-07-07

Review 4.  Metal-based complexes against SARS-CoV-2.

Authors:  Kyriacos Ioannou; Manos C Vlasiou
Journal:  Biometals       Date:  2022-03-24       Impact factor: 3.378

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.